Manali Petrochemicals shuts Plant 1 for scheduled maintenance

The intimation was submitted under Regulation 30 of the SEBI (Listing Obligations and Disclosure standards) Regulations, 2015. G Sri Vignesh, Company Secretary, signed the disclosure on June 23, 2026.

The company operates two manufacturing facilities in Chennai:

Manali Petrochemicals has reported its audited financial results to the quarter and year ended March 31, 2026, delivering strong development across key metrics. The company recorded a consolidated net profit of INR 1,299.50 crore to the fiscal year, a significant increase from INR 293.10 crore in the previous year. Total income to the year stood at INR 10,698.50 crore, compared to INR 9,216.30 crore in FY25. The results reflect improved raw material efficiencies, better realizations, and steady contributions from overseas subsidiaries.

to the quarter ended March 31, 2026, Manali Petrochemicals delivered a notable year-on-year improvement across all key parameters. Consolidated net profit came in at 290m Rupees, compared to 108m Rupees in the same quarter of the previous year. Revenue to the quarter stood at 3b Rupees versus 2.3b Rupees on a YoY basis. EBITDA to the quarter was 434m Rupees against 210m Rupees in the corresponding prior-year period, with EBITDA margin expanding significantly to 14.85% from 9.13% YoY. The standalone total income to the quarter was INR 2,567.10 crore, up from INR 2,061.40 crore in the previous quarter, while the standalone Profit Before Tax stood at INR 327.40 crore, compared to INR 50.90 crore in the preceding quarter.

The following table presents the Q4 year-on-year performance highlights:

The annual performance reflects a strong recovery and development trajectory to the company. The following table summarises the consolidated financial performance to the year and quarter:

The board has recommended a dividend of INR 0.50 per equity share, representing 10%, subject to the approval of shareholders at the ensuing Annual General Meeting.

The Board of Directors, in their meeting held on might 21, 2026, approved the audited financial results under Regulation 33 of the SEBI (Listing Obligations and Disclosure standards) Regulations, 2015. The board also approved the re-appointment of Mr. Thanjavur Kanakaraj Arun as an Independent Director to a second term of five years efficiently from September 29, 2026, subject to shareholder approval. Additionally, the board approved seeking member consent through a postal ballot to this re-appointment and to revising the remuneration of Mr. R Chandrasekar, MD & CEO, and Mr. G R Sridhar, Wholetime Director.

The company attributed the improved performance to strategic raw material purchasing and selective market participation amid unfolding international events. Consolidated results were supported by the steady performance of overseas subsidiaries. Mr. Ashwin Muthiah, Chairman, noted that improved raw-material efficiencies, better realizations, and contributions from overseas subsidiaries supported the results. He emphasized the continuous focus on internal cost discipline and productivity gains. regulation remains cautious on the near-term market outlook given continuing evaporative environment in input costs and global trade conditions.